UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 25

Sortiert nach

Genetic manipulation and immortalized culture of ex vivo primary human germinal center B cells

Nature protocols, 2021-05, Vol.16 (5), p.2499-2519

2021

Volltextzugriff (PDF)

Genomic and transcriptomic analysis of a library of small cell lung cancer patient-derived xenografts

Nature communications, 2022-04, Vol.13 (1), p.2144-2144, Article 2144

2022

Volltextzugriff (PDF)

WEE1 inhibition enhances the antitumor immune response to PD-L1 blockade by the concomitant activation of STING and STAT1 pathways in SCLC

Cell reports (Cambridge), 2022-05, Vol.39 (7), p.110814-110814, Article 110814

2022

Volltextzugriff (PDF)

Functional interplay of Epstein-Barr virus oncoproteins in a mouse model of B cell lymphomagenesis

Proceedings of the National Academy of Sciences - PNAS, 2020-06, Vol.117 (25), p.14421-14432

2020

Volltextzugriff (PDF)

Erk Negative Feedback Control Enables Pre-B Cell Transformation and Represents a Therapeutic Target in Acute Lymphoblastic Leukemia

Cancer cell, 2015-07, Vol.28 (1), p.114-128

2015

Volltextzugriff (PDF)

Genetic modification of primary human B cells to model high-grade lymphoma

Nature communications, 2019-10, Vol.10 (1), p.4543-16, Article 4543

2019

Volltextzugriff (PDF)

Should WEE(1) CHK(1) in on the FAM(122A)ily?

Molecular cell, 2020-11, Vol.80 (3), p.377-378

2020

Volltextzugriff (PDF)

MAPK pathway activation selectively inhibits ASCL1-driven small cell lung cancer

iScience, 2021-11, Vol.24 (11), p.103224-103224, Article 103224

2021

Volltextzugriff (PDF)

Cascade testing for hereditary cancer in Singapore: how population genomics help guide clinical policy

Familial cancer, 2024-06, Vol.23 (2), p.133-140

2024

Volltextzugriff (PDF)

BCL6-Mediated Escape from Negative Selection Enables RAS-Driven B-Cell Transformation

Blood, 2022-11, Vol.140 (Supplement 1), p.9177-9178

2022

Volltextzugriff (PDF)

Abstract LB186: MAPK pathway activation represents a therapeutic vulnerability in ASCL1 -driven SCLC

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.LB186-LB186

2021

Volltextzugriff (PDF)

Signalling input from divergent pathways subverts B cell transformation

Nature (London), 2020-07, Vol.583 (7818), p.845-851

2020

Volltextzugriff (PDF)

Targeting MEK in vemurafenib-resistant hairy cell leukemia

Leukemia, 2019-02, Vol.33 (2), p.541-545

2019

Volltextzugriff (PDF)

Abstract 5469: RAS and STAT5 pathway lesions are mutually exclusive in B-cell malignancies through mechanisms of biochemical cross-inhibition

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.5469-5469

2018

Volltextzugriff (PDF)

Combination Therapy With MDM2 and MEK Inhibitors Is Effective in Patient-Derived Models of Lung Adenocarcinoma With Concurrent Oncogenic Drivers and MDM2 Amplification

Journal of thoracic oncology, 2023-09, Vol.18 (9), p.1165-1183

2023

Volltextzugriff (PDF)

cfDNA methylome profiling for detection and subtyping of small cell lung cancers

Nature cancer, 2022-10, Vol.3 (10), p.1260

2022

Volltextzugriff (PDF)

BCL6 Is Critical to Overcome Oncogene-Induced Senescence in RAS-Mediated B Cell Transformation

Blood, 2016-12, Vol.128 (22), p.438-438

2016

Volltextzugriff (PDF)

Abstract 3858: Exploring Exportin-1 as a therapeutic vulnerability in squamous cell carcinoma

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.3858-3858

2023

Volltextzugriff (PDF)

Abstract 6127: MDM2 inhibition in combination with MEK inhibition in pre-clinical models of lung adenocarcinomas with MDM2 amplification

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.6127-6127

2023

Volltextzugriff (PDF)

Acquired CARD11 mutation promotes BCR independence in Diffuse Large B Cell Lymphoma

JCO precision oncology, 2021-01, Vol.5, p.145

2021

Volltextzugriff (PDF)

Abstract 90: STAT3-driven MAPK activation represents a therapeutic vulnerability in ASCL1 high SCLC

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.90-90

2022

Volltextzugriff (PDF)

Abstract 6238: Profiling of the circulating cell-free DNA methylome for detection and subtyping of small cell lung cancers

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.6238-6238

2022

Volltextzugriff (PDF)

Cytokine receptor IL27RA is an NF-κB–responsive gene involved in CD38 upregulation in multiple myeloma

Blood advances, 2023-08, Vol.7 (15), p.3874-3890

2023

Volltextzugriff (PDF)

Abstract 5214: Expanding the spectrum of germline-driven cancers by leveraging population-scale targeted tumor and normal sequencing

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.5214-5214

2023

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(25)

Sprache

Englisch
(25)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(13)
Humans
(10)
Life Sciences & Biomedicine
(10)
Animals
(7)
Mice
(7)
Oncology
(7)
Cell Line, Tumor
(5)
Mutation
(5)
Cell Biology
(4)
Lung Neoplasms - Pathology
(4)
Lymphocytes B
(4)
Cell Culture
(3)
Cell Differentiation
(3)
Genetic Transformation
(3)
Lung Neoplasms - Genetics
(3)
Multidisciplinary Sciences
(3)
Myc Protein
(3)
Patients
(3)
Science & Technology - Other Topics
(3)
Small Cell Lung Carcinoma - Pathology
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Genetic manipulation and immortalized culture of ex vivo primary human germinal center B cells

Genomic and transcriptomic analysis of a library of small cell lung cancer patient-derived xenografts

WEE1 inhibition enhances the antitumor immune response to PD-L1 blockade by the concomitant activation of STING and STAT1 pathways in SCLC

Functional interplay of Epstein-Barr virus oncoproteins in a mouse model of B cell lymphomagenesis

Erk Negative Feedback Control Enables Pre-B Cell Transformation and Represents a Therapeutic Target in Acute Lymphoblastic Leukemia

Genetic modification of primary human B cells to model high-grade lymphoma

Should WEE(1) CHK(1) in on the FAM(122A)ily?

MAPK pathway activation selectively inhibits ASCL1-driven small cell lung cancer

Cascade testing for hereditary cancer in Singapore: how population genomics help guide clinical policy

BCL6-Mediated Escape from Negative Selection Enables RAS-Driven B-Cell Transformation

Abstract LB186: MAPK pathway activation represents a therapeutic vulnerability in ASCL1 -driven SCLC

Signalling input from divergent pathways subverts B cell transformation

Targeting MEK in vemurafenib-resistant hairy cell leukemia

Abstract 5469: RAS and STAT5 pathway lesions are mutually exclusive in B-cell malignancies through mechanisms of biochemical cross-inhibition

Rlf-Mycl Gene Fusion Drives Tumorigenesis and Metastasis in a Mouse Model of Small Cell Lung Cancer

Combination Therapy With MDM2 and MEK Inhibitors Is Effective in Patient-Derived Models of Lung Adenocarcinoma With Concurrent Oncogenic Drivers and MDM2 Amplification

cfDNA methylome profiling for detection and subtyping of small cell lung cancers

BCL6 Is Critical to Overcome Oncogene-Induced Senescence in RAS-Mediated B Cell Transformation

Abstract 3858: Exploring Exportin-1 as a therapeutic vulnerability in squamous cell carcinoma

Abstract 6127: MDM2 inhibition in combination with MEK inhibition in pre-clinical models of lung adenocarcinomas with MDM2 amplification

Acquired CARD11 mutation promotes BCR independence in Diffuse Large B Cell Lymphoma

Abstract 90: STAT3-driven MAPK activation represents a therapeutic vulnerability in ASCL1 high SCLC

Abstract 6238: Profiling of the circulating cell-free DNA methylome for detection and subtyping of small cell lung cancers

Cytokine receptor IL27RA is an NF-κB–responsive gene involved in CD38 upregulation in multiple myeloma

Abstract 5214: Expanding the spectrum of germline-driven cancers by leveraging population-scale targeted tumor and normal sequencing

Suchergebnisse filtern